1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Diabetic Macula Edema: new trials by email Literature Review of Diabetic Macula Edema trials Research Report on Diabetic Macula Edema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema Brolucizumab, Aflibercept - Diabetic Macula Edema | Phase 3 | Withdrawn | Novartis Pharmaceuticals | 2021-02-01 | 2021-03-04 |
aflibercept (1) · brolucizumab (1)